Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rapid platelet-function assay: an automated and quantitative cartridge-based method

J W Smith1, S R Steinhubl, A M Lincoff

  • 1Accumetrics Inc, San Diego, CA, USA.

Circulation
|February 9, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction.

NEJM evidence·2025
Same author

Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.

Alimentary pharmacology & therapeutics·2018
Same author

Differences in prevalence of community-associated MRSA and MSSA among U.S. and non-U.S. born populations in six New York Community Health Centers.

Travel medicine and infectious disease·2016
Same author

αIIbβ3: structure and function.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Current contradictions in adolescent theory.

Journal of youth and adolescence·2014
Same author

The sweet side of life: nectar sugar type and concentration preference in Wahlberg's epauletted fruit bat.

Comparative biochemistry and physiology. Part A, Molecular & integrative physiology·2012
Same journal

Eugene Braunwald, MD, 1929-2026.

Circulation·2026
Same journal

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Circulation·2026
Same journal

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Circulation·2026
Same journal

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Circulation·2026
Same journal

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same journal

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026
See all related articles

A new rapid platelet-function assay (RPFA) offers quick, point-of-care measurement of platelet activity. This assay effectively monitors glycoprotein (GP) IIb/IIIa receptor blockade by antagonists, aiding in managing antithrombotic therapy.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Biotechnology

Background:

  • Platelet glycoprotein (GP) IIb/IIIa receptor is crucial for thrombus formation.
  • GP IIb/IIIa antagonists like abciximab and small-molecule RGD-based agents prevent thrombotic events.
  • Interindividual variability in response to antagonists necessitates monitoring to balance efficacy and bleeding risk.

Purpose of the Study:

  • To develop and validate a rapid point-of-care assay for assessing platelet function.
  • To quantitatively measure the competence of the GP IIb/IIIa receptor.
  • To monitor the effectiveness of GP IIb/IIIa antagonists in clinical settings.

Main Methods:

  • Developed a rapid platelet-function assay (RPFA) using fibrinogen-coated beads and a microprocessor-controlled system.

Related Experiment Videos

  • Whole blood is mixed with reagents in a cartridge, detecting platelet agglutination.
  • Assay provides quantitative digital results within 3 minutes without blood dilution.
  • Main Results:

    • RPFA results correlated strongly with conventional turbidimetric platelet aggregation (r2=0.95).
    • RPFA measurements showed high correlation with the percentage of free GP IIb/IIIa molecules (r2=0.96).
    • The assay demonstrated excellent agreement with established methods, with minimal mean differences.

    Conclusions:

    • The RPFA is a rapid and reliable tool for assessing platelet function.
    • The assay accurately reflects GP IIb/IIIa receptor blockade by antagonists.
    • RPFA provides valuable point-of-care information for managing antithrombotic therapies.